Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billion in venture loans to thousands of companies. The company was founded in 2003 and is headquartered in Farmington, Connecticut.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/5/2010
Ticker Symbol:
HRZN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2020 | Getaround | Debt Financing | 25M |
7/2022 | Divergent | Debt Financing | 80M |
12/2017 | Aerin Medical | Debt Financing | 15M |
10/2022 | Kodiak Robotics | Debt Financing | 30M |
6/2021 | Cerecor | Post-IPO Debt | 20M |
6/2018 | Ontrak | Post-IPO Debt | 10M |
8/2016 | Receptiv | Venture Round | 6.5M |
7/2017 | PebblePost | Series B | 15M |
4/2017 | IgnitionOne | Debt Financing | 12M |
7/2022 | INBRACE | Debt Financing | 0 |
11/2007 | Ambit Biosciences | Series D | 49.3M |
5/2019 | Meditrina, Inc | Debt Financing | 5M |
7/2014 | Mblox | Debt Financing | 43.5M |
9/2013 | Inotek Pharmaceuticals | Debt Financing | 0 |
8/2021 | Nogin | Debt Financing | 15M |
5/2020 | Ceribell | Debt Financing | 20M |
8/2021 | Cerecor | Post-IPO Debt | 10M |
12/2020 | IDbyDNA | Debt Financing | 10M |
1/2018 | IntelePeer | Debt Financing | 15M |
5/2015 | SavingStar | Debt Financing | 5M |
2/2015 | NinePoint Medical | Debt Financing | 15M |
3/2016 | Avalanche Technology | Debt Financing | - |
8/2012 | Valore | Debt Financing | 5M |
4/2015 | ScoreBig | Debt Financing | 7M |
6/2013 | Overture Networks | Debt Financing | 10M |
12/2014 | Palatin Technologies | Post-IPO Debt | 10M |
9/2014 | Argos Therapeutics | Post-IPO Debt | 25M |
11/2020 | Sonex Health | Debt Financing | 7.5M |
4/2019 | Mustang Bio | Post-IPO Debt | 20M |
10/2022 | Robin Healthcare | Debt Financing | 7M |
3/2016 | ScoreBig | Debt Financing | 2M |
12/2016 | Strongbridge Biopharma | Post-IPO Debt | 40M |
7/2017 | Titan Pharmaceuticals | Post-IPO Debt | 10M |
3/2022 | Secure Transfusion Services | Debt Financing | 15M |
3/2010 | Enphase Energy | Venture Round | 0 |
5/2022 | Soli Organic | Debt Financing | 0 |
7/2014 | SpringCM | Debt Financing | 6M |
6/2021 | LiquiGlide | Debt Financing | 8M |
7/2021 | RepTrak | Debt Financing | 10M |
6/2015 | Medsphere Systems | Debt Financing | 7.5M |
7/2015 | Bridge2 Solutions | Debt Financing | 5M |
8/2021 | Embody | Venture Round | 11.5M |
7/2019 | Evelo | Post-IPO Debt | 45M |
3/2022 | Aerobiotix | Debt Financing | 10M |
10/2021 | Stealth BioTherapeutics | Post-IPO Debt | 25M |
8/2021 | Embody | Debt Financing | 9M |
1/2022 | Interior Define | Debt Financing | 30M |
1/2016 | Digital Signal | Debt Financing | 12M |
8/2022 | PDS Biotechnology Corporation | Post-IPO Debt | 25M |
4/2005 | Intarcia Therapeutics | Debt Financing | 10M |
6/2014 | GenePeeks | Debt Financing | 3M |
12/2020 | Corinth MedTech | Debt Financing | 5M |
6/2018 | Audacy | Debt Financing | 4M |
2/2014 | AccuVein | Debt Financing | 8M |
3/2006 | Copan Systems | Series C | 17.5M |
12/2008 | Tagged | Debt | 5M |
2/2019 | CSA Medical | Venture Round | 45.2M |
3/2012 | Radisphere Radiology | Debt Financing | 15M |
4/2019 | Encore Dermatology | Debt Financing | 20M |
12/2022 | Slingshot Aerospace | Debt Financing | - |
6/2018 | Audacy | Debt Financing | 4M |
10/2014 | ZetrOZ | Debt Financing | 5M |
7/2022 | Divergent | Private Equity Round | 0 |
1/2018 | Conventus Orthopaedics | Debt Financing | 12M |
6/2014 | Social Intelligence | Debt Financing | - |
1/2021 | Alula Holdings | Debt Financing | 13M |
1/2021 | Canary Medical | Debt Financing | 20M |
10/2015 | New Haven Pharmaceuticals | Debt Financing | 6.3M |
5/2020 | Magnolia Medical Technologies | Debt Financing | 20M |
12/2021 | IMV Inc | Post-IPO Debt | 25M |
2/2021 | Fingerlix | Series C | 0 |
12/2013 | Mederi Therapeutics | Debt Financing | 10M |
1/2016 | Nomi | Debt Financing | 15M |
6/2020 | Emalex Biosciences | Debt Financing | 15M |
12/2014 | Interleukin Genetics | Post-IPO Debt | 5M |
2/2021 | Maverix Platforms | Series C | 0 |
7/2019 | OutboundEngine | Debt Financing | 8M |
7/2018 | New Signature | Debt Financing | 15M |
10/2020 | Topia | Debt Financing | 15M |
4/2023 | Unagi Scooters | Debt Financing | 10M |
9/2014 | IntegenX | Debt Financing | 10M |
3/2020 | Castle Creek Biosciences | Debt Financing | 20M |
5/2015 | SilkRoad Technology | Debt Financing | 7.5M |
11/2008 | Revance Therapeutics | Debt Financing | 0 |
6/2009 | Grab Media | Private Equity Round | 0 |
7/2018 | MacuLogix | Debt Financing | 10M |
11/2021 | Everstream Analytics | Debt Financing | 5M |
10/2014 | InVisage Technologies | Debt Financing | - |
7/2022 | Nexii | Venture Round | 34.5M |
7/2022 | Nexii | Venture Round | 0 |
7/2022 | INBRACE | Debt Financing | 0 |
7/2022 | Divergent | Private Equity Round | 0 |
5/2022 | Soli Organic | Debt Financing | 0 |
3/2022 | Secure Transfusion Services | Debt Financing | 0 |
3/2022 | Aerobiotix | Debt Financing | 0 |
1/2022 | Interior Define | Debt Financing | 0 |
12/2021 | IMV Inc | Post-IPO Debt | 0 |
11/2021 | Everstream Analytics | Debt Financing | 0 |
10/2021 | Stealth BioTherapeutics | Post-IPO Debt | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|